Back to Home

Rapid Reviews in Retina™: Emerging Updates from Fall 2023 – Addressing the Wealth of New Data in Treatments for nAMD and DME

3 Activities Available!

AAO Rapid Review Plus Insights on Recent Clinical Data

AAO Rapid Review Plus Insights on Recent Clinical Data

This online activity is designed to update clinicians on recent data presented at the end of 2023, with a focus on data released at AAO 2023, held November 3-6 in San Francisco, California.

View Details


The Retina Society Rapid Review

The Retina Society Rapid Review

This online activity is designed to update clinicians on data presented at the Retina Society 56th Annual Meeting, held October 11-14 in New York, NY.

View Details


EURETINA Rapid Review

EURETINA Rapid Review

This online activity is designed to update clinicians on data presented at the 23rd EURETINA Congress, held from October 5-8 in Amsterdam, the Netherlands.

View Details

Overview

Prominent eye care meetings, such as the AAO Annual Meeting, the EURETINA Congress, and the Retina Society Annual Scientific Meeting, are premier opportunities to learn about emerging data that has the potential to change the management of neovascular retinal disease. However, clinicians cannot attend all major conferences or retain all the highlights from meetings they do attend. This Rapid Reviews in Retina program provides concise discussions of recent data on advances in the management of nAMD and DME, as well as faculty discussions regarding how these data may shape patient care.


Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.


Acknowledgment of Commercial Support

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.